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Anasarca and Low Electrocardiogram Voltage
In a recent article in the Journal, Madias et al. (1) reported an
inverse relationship between electrocardiogram (ECG) voltage and
changes in body weight due to fluid loss or retention in patients
with anasarca. The investigators could find no reference in the
literature to a link between low ECG voltage and anasarca. A
direct correlation has been reported, however, between ECG
voltage and the concentration of serum albumin (2). Anasarca is
frequently associated with a lowered serum albumin concentration
(3). To ascertain how much the Madias et al. (1) study expands
existing knowledge, it would be necessary to correlate the observed
changes in ECG voltage with concomitant changes in serum
albumin. Are the investigators able to do this?
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REPLY
I am grateful to Dr. Brennan for directing me to literature
describing a direct correlation of albumin and amplitude of QRS
complexes (1). To respond to his inquiry I have modeled an
analysis of our data after the study of Dr. Heaf (1). Our patients
were critically ill, were followed for a long time (34.5  36.7 days)
(2) and inevitably experienced gradual reduction of albumin,
despite our concerted efforts to use enteral and/or parenteral
feeding. We had not measured albumin daily, but frequently.
Thus, I was able to employ values that were the closest to the
admission and peak weight albumin values of our patients. The
albumin levels available for my analysis were checked on days 0.61
 1.71 for admission, and on days 0.43  1.79 of peak weight
time point.
Correlation of the sums of all 12 QRS leads (QRS) (2) from
admission with the corresponding albumin values revealed an r 
0.057 and a p  0.77. A similar analysis, carried out for the
QRSs obtained on the day of the peak weight and the corre-
sponding albumin values, showed an r  0.38 and a p  0.04.
Correlation of the percent change in the QRSs between admis-
sion and points of the peak body weights, with the percent change
in the corresponding albumin values, revealed an r  0.37 and a
p  0.053.
The difference in our results from the admission time point and
the time of peak weight is hard to explain. If there was a real
relationship between QRS amplitude and albumin, such a discrep-
ancy should not have been encountered. Moreover, I find it odd to
correlate absolute values of albumin with absolute values of
amplitude of QRS complexes, taking into consideration that the
latter can vary widely among both healthy subjects and patients,
while the normal range of the former is 3.3 to 5.3 g/dl in our
laboratory.
I find the correlation of change in each of the two correlates
more meaningful scientifically, and in our data we found an almost
significant association between the drop of albumin and loss of
QRS amplitudes. The correlation coefficient was much smaller
than the one we reported (r  0.61) (2) for the association of
weight gain and QRS drop. However, some association may exist
between albumin and QRS amplitudes, and may be confirmed in
patients in whom both daily electrocardiograms and albumin
measurements are implemented.
Does this mean that the hypoalbuminemia was causally related
to the drop of QRS in our patients, or was this biochemical
abnormality “an innocent bystander”? Innocent it is not, for
certainly it contributes to the extent of water retention; however,
the causative mechanism for the drop in QRSs must have been
the weight gain (or fluid retention). Correlation of % weight gain
and % albumin drop in our 28 patients was poor (r  0.02, p 
0.9); also, correlation of the % weight loss and % albumin rise in
9 patients was poor (r  0.5, p  0.1). It would have been very
interesting to have data on weight change in the patients reported
by Heaf (1).
There is evidence that edema fluid has low resistivity (3); thus,
its effect on the transfer of cardiac potentials from the heart to the
body surface can be explained by Ohm’s law. I am not aware of any
work ascribing any mechanistic role for albumin per se in modu-
lating the ECG voltage. Finally, the fact that patient 26 (2) gained
122.4 lb and lost 68.3% of his QRS, while his albumin increased
from 1.8 g/dl to 2.7 g/dl, and subsequently lost 77.4 lb and gained
185.9% of his QRS (Fig. 6 of Madias et al. [2]) while his albumin
increased merely from 2.9 to 3.0 g/dl, casts serious doubt on the
contention that a causative relation between albumin and QRS
amplitudes really exists.
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Pulse Wave Reflection
in Pulmonary Hypertension
In a recent Journal study, Nakayama et al. (1) showed that patients
with chronic pulmonary thromboembolism (CPTE) had a higher
pulmonary artery augmentation index and shorter inflection time
than patients with primary pulmonary hypertension (PPH). Data
were obtained on a large study population using fluid-filled
catheters. Their findings—that increased and anticipated pulse
wave reflection may help differentiate CPTE from PPH—are
consistent with our recent reports, where we used high-fidelity
catheters in a smaller population (2,3). One hypothesis is that the
functional reflection site could be more proximal in CPTE than in
PPH (1–4). Indeed, in PPH, pulmonary obstruction involves
distal, medium-to-small-sized muscular arteries, whereas in
CPTE, endothelialized residua narrow and stiffen proximal, major
pulmonary arteries. However, we see a number of problems in the
present study (1) with regard to the recording system, calculation
of pressure reflection and discussion of the data.
First, signal distortions are unavoidable when using fluid-filled
catheters, especially when pulsatile pressure characteristics are
studied (5,6). As a result, the numerical data reported by Na-
kayama et al. require careful scrutiny owing to the previously
documented pressure artifacts. The markedly negative values of the
augmentation index (up to 80%) (1) correspond to pulmonary
artery pressure shapes and reflection characteristics that have not
been previously documented in PPH using high-fidelity catheters
(7–10), and that we have never observed in our PPH patients (2,3).
The pressure wave shape shown in Figure 1 of their study (1) is
inconsistent with the prolonged time-to-peak pressure previously
documented in PPH (8).
Second, identification of both the onset of the pressure pulse
and the inflection point is not as easy as their study suggests. This
may sound trivial but can result in large differences in time intervals
and augmentation index. Previous studies have shown that the
simultaneous analysis of the pulmonary artery pressure derivative
with time significantly improves the identification of the inflection
point (3,11). Numerous other factors may influence the numerical
results, but unfortunately the investigators gave no information as
to the inter- and intraobserver reproducibility of their measure-
ments.
Furthermore, Murgo et al. (11) have shown that negative values
of the augmentation index imply smaller or more diffuse reflections
than other patterns. The results of the Nakayama et al. (1) study
for PPH are thus inconsistent with the numerous reports demon-
strating increased wave reflections in PPH (7–10).
In conclusion, the study of Nakayama et al. (1) is similar to
previous studies demonstrating markedly increased wave reflection
in CPTE (2–4) and suggesting that the timing and extent of wave
reflection might be useful in the differential diagnosis of CPTE
and PPH (2,3). The numerical values of the reflection indices
calculated from fluid-filled catheters require careful scrutiny,
whereas high-fidelity catheters must be preferred when attempting
to obtain a reliable insight into pulmonary artery pathophysiology.
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